Ibsa International Sa
Ibsa International SA, headquartered in Switzerland (CH), is a prominent player in the pharmaceutical and healthcare industry. Founded in 1945, the company has established a strong presence in Europe, Asia, and Latin America, focusing on innovative solutions in the fields of endocrinology, urology, and pain management. Ibsa International is renowned for its unique range of products, including advanced formulations and therapies that cater to specific medical needs. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted name in the market. With a reputation for quality and efficacy, Ibsa International continues to achieve notable recognition within the healthcare sector, making strides in improving patient outcomes globally.
DitchCarbon Score
How does Ibsa International Sa's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ibsa International Sa's score of 14 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ibsa International Sa's reported carbon emissions
In 2023, Ibsa International SA reported total carbon emissions of approximately 34,767,000 kg CO2e. This figure includes 12,499,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from manufacturing and heating processes, and 9,199,000 kg CO2e from Scope 2 emissions, primarily related to purchased electricity. Additionally, Scope 3 emissions accounted for about 13,069,000 kg CO2e, with significant contributions from employee commuting and waste generated in operations. In previous years, emissions have shown variability, with 2022 emissions recorded at approximately 12,518,000 kg CO2e for Scope 1 and 7,950,000 kg CO2e for Scope 2. The company has not disclosed specific reduction targets or initiatives, indicating a lack of formal commitments to reduce emissions at this time. Overall, Ibsa International SA's emissions profile highlights the importance of addressing both direct and indirect emissions as part of their climate strategy, particularly in the context of their operations based in Switzerland (CH).
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | 00,000,000 | 00,000,000 |
| Scope 2 | 3,999,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | - | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ibsa International Sa is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
